Serum Vascular Endothelial Growth Factor Levels before and after Intravitreous Ranibizumab Injection for Retinopathy of Prematurity

Table 1

Demographic characteristics of the infants with ROP.

Patient	Sex	Gestational age (week)	Birth weight (g)	Postmenstrual age at IVR (week)	Eye	Zone/stage	Plus disease	ROP regression	Recurrence
1	Female	30	1380	35^+3	Right	II/1	+	Yes	No
					Left	II/1	+	Yes	No
2	Male	30^+2	1400	39^+6	Right	II/2	+	Yes	No
					Left	II/2	+	Yes	No
3	Male	29^+4	1100	37	Right	II/2	+	Yes	No
					Left	II/2	+	Yes	No
4	Female	29^+6	1300	36^+3	Right	AP-ROP		Yes	No
					Left	AP-ROP		Yes	No
5	Female	28^+4	950	35^+6	Right	II/1	+	Yes	No
					Left	II/1	+	Yes	No
6	Female	27^+5	1280	32^+5	Right	AP-ROP		Yes	Yes
					Left	AP-ROP		Yes	Yes
7	Male	28^+2	950	36^+5	Right	II/2	+	Yes	Yes
					Left	II/2	+	Yes	Yes
8	Male	28^+4	1029	34^+1	Right	AP-ROP		Yes	Yes
					Left	AP-ROP		Yes	Yes
9	Male	29^+3	1500	34	Right	AP-ROP		Yes	No
					Left	AP-ROP		Yes	No
10	Male	27^+6	1200	32^+2	Right	AP-ROP		Yes	No
					Left	AP-ROP		Yes	No
11	Male	30^+1	1300	38^+3	Right	AP-ROP		Yes	Yes
					Left	AP-ROP		Yes	Yes
12	Female	28^+5	1310	38^+3	Right	II/2	+	Yes	No
					Left	II/3	+	Yes	No
13	Male	27^+1	980	36^+6	Right	II/2	+	Yes	Yes
					Left	II/2	+	Yes	Yes
14	Female	30	1465	35^+3	Right	I/2	+	Yes	No
					Left	I/2	+	Yes	No
15	Male	30^+3	1510	34^+3	Right	I/2	+	Yes	No
					Left	I/1	+	Yes	No